Seagrove’s Blue book and Original Research Series cover timely topics within the Diabetes and Oncology disease states, offering readers carefully researched and vetted data points and clinical education material.
Oncology Bluebook
Our most ambitious project, this resource serves as the Rosetta Stone for all of Seagrove’s therapeutic market primers. 400+ pages of detailed review of 13 different tumor types — clinical outcomes, market landscapes, epidemiology statistics, company profiles, pipeline analyses, product snapshots — all in one place.
Diabetes Bluebook
A widely-read publication, the Seagrove Diabetes Blue Book is a statistical almanac of all things diabetes. The Blue Book is updated annually and includes the following sections (total of 316 pages):
Disease Overview, Epidemiology, Insulin Pumps, Glucose Sensing, Therapeutics, Early-Stage Technologies
CAR T Market Primer
Seagrove’s first Oncology Forum publication, the 2020 CAR T Market Primer covers General Oncology Market Statistics, History of CAR T, Company Profiles and Pipelines, and Clinical Outcomes/Data. (95 pages)
Breast Cancer Market Primer
An in-depth review of one of the market’s most important and competitive tumor types, this primer provides content focused on clinical outcomes, pipelines, commercial product brand messaging, epidemiology statistics, treatment algorithms, and companion diagnostics.
Lung Cancer Market Primer
Seagrove’s latest oncology market primer, this publication provides in-depth coverage of company pipelines, clinical trial outcomes, market dynamics, product profiles, and companion diagnostic companies.(170+ pages)
